We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VCYT market cap is 2.5B. The company's latest EPS is USD 0.3097 and P/E is 102.81.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 98.2M | 96.84M | 114.43M | 115.86M | 118.63M |
| Operating Income | -34.06M | -4.23M | 4.61M | 12.2M | 4.23M |
| Net Income | -28.29M | -1.86M | 5.73M | 15.16M | 5.11M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 117.48M | 219.51M | 296.54M | 361.05M | 445.76M |
| Operating Income | -35.39M | -81.9M | -41.08M | -84.35M | 16.81M |
| Net Income | -34.91M | -75.56M | -36.56M | -74.4M | 24.14M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.11B | 1.2B | 1.23B | 1.28B | 1.3B |
| Total Liabilities | 70.8M | 81.42M | 101.8M | 98.98M | 124.07M |
| Total Equity | 1.04B | 1.12B | 1.13B | 1.18B | 1.18B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 457.16M | 1.19B | 1.16B | 1.11B | 1.3B |
| Total Liabilities | 35.93M | 91.31M | 81.22M | 70.8M | 124.07M |
| Total Equity | 421.23M | 1.1B | 1.08B | 1.04B | 1.18B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 44.22M | -8.97M | 20.61M | 50.57M | 75.1M |
| Investing | 15.11M | 2.88M | 108k | -2.13M | -56.28M |
| Financing | 2.84M | -864k | -875k | 9.41M | 4.9M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.71M | -31.62M | 7.54M | 44.22M | 75.1M |
| Investing | -3.84M | -739.21M | -29.39M | 15.11M | -56.28M |
| Financing | 203.6M | 596.32M | 3.49M | 2.84M | 4.9M |
| Market Cap | 2.5B |
| Price to Earnings Ratio | 102.81 |
| Price to Sales Ratio | 5.57 |
| Price to Cash Ratio | 10.38 |
| Price to Book Ratio | 2.11 |
| Dividend Yield | - |
| Shares Outstanding | 77.94M |
| Average Volume (1 week) | 702.43k |
| Average Volume (1 Month) | 1.15M |
| 52 Week Change | 49.49% |
| 52 Week High | 47.3162 |
| 52 Week Low | 18.61 |
| Spread (Intraday) | 0.07 (0.22%) |
| Company Name | Veracyte Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.veracyte.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
